Sotetsuflavone

CAS : 2608-21-1

Ref. 3D-FS176755

Informations sur le produit

• Nom: Sotetsuflavone
• Synonymes: 3''',8-Biflavone,4',4''',5,5'',7''-pentahydroxy-7-methoxy- (7CI,8CI), 3′′′,8-Biflavone, 4′,4′′′,5,5′′,7′′-pentahydroxy-7-methoxy-, 8-[5-(5,7-Dihydroxy-4-oxo-4H-1-benzopyran-2-yl)-2-hydroxyphenyl]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4H-1-benzopyran-4-one, Sotetsuflavon, Sotetsuflavone (6CI), 4H-1-Benzopyran-4-one, 8-[5-(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl)-2-hydroxyphenyl]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-

Description

Sotetsuflavone is a natural flavone that has shown to have therapeutic potential in the treatment of cancer and infectious diseases. It is a potent inhibitor of mitochondrial membrane potential, which may be useful for treating cancer cells. Sotetsuflavone also inhibits the expression of epithelial mesenchymal transition (EMT) genes, which may be useful for treating squamous carcinoma. This compound has been shown to be a potential biomarker for various cancers and infectious diseases, including HIV/AIDS and tuberculosis. It can also affect the development of autoimmune diseases such as rheumatoid arthritis by inhibiting p-hydroxybenzoic acid synthesis and autophagy. Sotetsuflavone also inhibits apoptosis in experimental models, which may be an effective treatment option for chronic inflammation-mediated diseases such as Alzheimer's disease.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 552.48 g/mol
• Formule: C₃₁H₂₀O₁₀
• Degré de pureté: Min. 95%